| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 29, 2018 | May 31, 2018 | Cammarata Sue Chief Medical Officer | Buy | Melinta Therapeutics, Inc. /new/ | MLNT | $5 | $20,000 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.